-The Hindu Business Line   The general tendency among Indian policy makers currently is to blame international price movements for the rise in prices of essential food items in India. The extent to which this claim is valid is assessed by examining the specific case of wheat. It is no secret that Indian food prices are increasingly affected by international prices. Ever since 2002, when all quantitative restrictions on Indian imports of agricultural...

-The Indian Express West Bengal is not new to chit fund scams. What is unique to the Saradha Group scandal is how it targeted the poorest and the most marginalised, leaving them on the verge of devastation. From 17-year-old agents who raised money from depositors to 50-year-old widows who invested money, the Saradha Group didn't discriminate in roping them in. Since the house of cards started collapsing, two agents and two...

-The Business Standard It will make the coercive powers of the land acquisition law irrelevant, though including it in the central Bill would be unconstitutional The proposal to amend the central Land Acquisition Bill to provide for leasing of land rather than acquiring it is just not constitutionally feasible. Land is a state subject and the Centre cannot legislate on leasing at all. But as an idea it is great and should...

-Live Mint Vedanta can mine bauxite in Orissa with gram sabha nod, some Karnataka iron ore mines to reopen Two key judgements passed by the Supreme Court on Thursday bode well for India's troubled natural resources sector, keeping alive Vedanta Resources Plc's hopes of mining bauxite in Orissa and promising an alleviation of raw material shortages at steel makers by partly lifting a ban on iron ore mining in Karnataka. The country's top...

The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...